Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
11.96
-0.17 (-1.40%)
Apr 9, 2026, 3:00 PM CST
SHA:603811 Market Cap
SHA:603811 has a market cap or net worth of 3.8 billion as of April 9, 2026. Its market cap has increased by 42.61% in one year.
Market Cap
3.80B
Enterprise Value
3.72B
Revenue
790.86M
Ranking
n/a
PE Ratio
17.07
Stock Price
11.96
Market Cap Chart
Since March 15, 2017, SHA:603811's market cap has increased from 1.93B to 3.80B, an increase of 96.54%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 3.85B | 15.52% |
| Dec 31, 2025 | 3.34B | 32.01% |
| Dec 31, 2024 | 2.53B | -25.55% |
| Dec 29, 2023 | 3.39B | 3.77% |
| Dec 30, 2022 | 3.27B | -13.80% |
| Dec 31, 2021 | 3.79B | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Jiaoda Onlly Co.,Ltd | 4.05B |
| Qianjiang Yongan Pharmaceutical | 4.04B |
| PKU HealthCare Corp.,Ltd. | 4.02B |
| Guizhou Yibai Pharmaceutical | 3.97B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 3.95B |
| Honz Pharmaceutical | 3.95B |
| Tibet AIM Pharm. | 3.87B |
| Huaren Pharmaceutical | 3.83B |